These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6366127)

  • 1. Autologous bone-marrow transplantation: host effects of high-dose BCNU.
    Takvorian T; Parker LM; Hochberg FH; Canellos GP
    J Clin Oncol; 1983 Oct; 1(10):610-20. PubMed ID: 6366127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
    Phillips GL; Fay JW; Herzig GP; Herzig RH; Weiner RS; Wolff SN; Lazarus HM; Karanes C; Ross WE; Kramer BS
    Cancer; 1983 Nov; 52(10):1792-802. PubMed ID: 6354414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.
    Johnson DB; Thompson JM; Corwin JA; Mosley KR; Smith MT; de los Reyes RA; Daly MB; Petty AM; Lamaster D; Pierson WP
    J Clin Oncol; 1987 May; 5(5):783-9. PubMed ID: 3553437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early pulmonary toxicity after administration of high-dose BCNU.
    Litam JP; Dail DH; Spitzer G; Vellekoop L; Verma DS; Zander AR; Dicke KA
    Cancer Treat Rep; 1981; 65(1-2):39-44. PubMed ID: 6261949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.
    Hochberg FH; Parker LM; Takvorian T; Canellos GP; Zervas NT
    J Neurosurg; 1981 Apr; 54(4):455-60. PubMed ID: 6259300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose BCNU therapy with autologous bone marrow infusion: preliminary observations.
    Spitzer G; Dicke KA; Verma DS; Zander A; McCredie KB
    Cancer Treat Rep; 1979 Aug; 63(8):1257-64. PubMed ID: 383292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) autologous bone marrow transplantation therapy of refractory cancer: a preliminary report.
    Phillips GL; Fay JW; Herzig GP; NaPombejara C; Wolff SN
    Exp Hematol; 1979; 7 Suppl 5():372-83. PubMed ID: 400699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors.
    Spitzer G; Dicke KA; Litam J; Verma DS; Zander A; Lanzotti V; Valdivieso M; McCredie KB; Samuels ML
    Cancer; 1980 Jun; 45(12):3075-85. PubMed ID: 6992970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study.
    Stiff PJ; McKenzie RS; Potempa LD; Albain K; Koch D; Braud E; Bansal VK; Weidner MK; Lanzotti VJ; Chun HG
    J Clin Oncol; 1991 Aug; 9(8):1487-94. PubMed ID: 2072148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose combination alkylating agent therapy with autologous bone marrow rescue for refractory solid tumors.
    Slease RB; Benear JB; Selby GB; Reitz CL; Hughes WL; Watkins CL; Epstein RB
    J Clin Oncol; 1988 Aug; 6(8):1314-20. PubMed ID: 3045266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease.
    Ahmed T; Ciavarella D; Feldman E; Ascensao J; Hussain F; Engelking C; Gingrich S; Mittelman A; Coleman M; Arlin ZA
    Leukemia; 1989 Jan; 3(1):19-22. PubMed ID: 2642573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas.
    Mortimer JE; Hewlett JS; Bay J; Livingston RB
    J Neurooncol; 1983; 1(3):269-73. PubMed ID: 6088718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nursing management of the patient receiving high-dose BCNU with autologous bone marrow harvest.
    Gamel-Bentzel C
    J Neurosurg Nurs; 1982 Apr; 14(2):98-102. PubMed ID: 6288899
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinoma.
    Rushing DA; Friedenberg WR; Baldauf MC; Broste S; Gehlsen JA; Kriesel DH; Koontz DP; Rodvold KA
    Cancer; 1991 Aug; 68(4):720-4. PubMed ID: 1649684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy without autologous bone marrow transplantation in melanoma.
    Tchekmedyian NS; Tait N; Van Echo D; Aisner J
    J Clin Oncol; 1986 Dec; 4(12):1811-8. PubMed ID: 3537218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system.
    Wolff SN; Phillips GL; Herzig GP
    Cancer Treat Rep; 1987 Feb; 71(2):183-5. PubMed ID: 3026626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors.
    Papadakis V; Dunkel IJ; Cramer LD; Kramer E; Papadopoulos E; Goldman S; Packer RJ; Willoughby M; Baker D; Garvin J; Strandjord S; Coccia P; Kaplan AM; Klemperer M; Finlay JL
    Bone Marrow Transplant; 2000 Jul; 26(2):153-60. PubMed ID: 10918425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation.
    Neidhart J; Mangalik A; Kohler W; Stidley C; Saiki J; Duncan P; Souza L; Downing M
    J Clin Oncol; 1989 Nov; 7(11):1685-92. PubMed ID: 2478670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.
    Mbidde EK; Selby PJ; Perren TJ; Dearnaley DP; Whitton A; Ashley S; Workman P; Bloom HJ; McElwain TJ
    Br J Cancer; 1988 Dec; 58(6):779-82. PubMed ID: 2852028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation.
    Attal M; Canal P; Schlaifer D; Chatelut E; Dezeuze A; Huguet F; Payen C; Pris J; Laurent G
    J Clin Oncol; 1994 Jan; 12(1):141-8. PubMed ID: 8270970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.